You are here

CRISPR

Sean Parker-Backed ArsenalBio Wants To Create Better Weapons Against Cancer

Forbes

Fri, 10/18/19 - 09:41 am

precision medicine

Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs

Xconomy

Sat, 09/28/19 - 04:27 pm

Beam Therapeutics

CRISPR Gene-Editing May Offer Path To Cure For HIV, First Published Report Shows

NPR

Wed, 09/11/19 - 11:42 pm

Challenging CRISPR, Trucode Raises $34M for New Gene-Editing System

Xconomy

Tue, 09/10/19 - 10:39 am

CRISPR slows the growth of triple-negative breast cancer in mice

Fierce Biotech

Tue, 08/27/19 - 09:56 am

Boston Children's Hospital

triple negative breast cancer

Editas, Allergan launch first in vivo study of CRISPR-based medicine

BioPharma Dive

Thu, 07/25/19 - 12:00 pm

Editas Medicine

clinical trials

Using CRISPR to eliminate HIV

Fierce Biotech

Wed, 07/3/19 - 10:35 am

Patent office reopens major CRISPR battle between Broad Institute and Univ. of California

Stat

Tue, 06/25/19 - 07:22 pm

Broad Institute

University of California

A CRISPR alternative for editing genes without cutting

Fierce Biotech

Thu, 06/13/19 - 10:42 am

Columbia University

GSK partners with CRISPR pioneer Doudna to search for new drugs

Stat

Thu, 06/13/19 - 09:59 am

Research Roundup: New CRISPR, ALS, Colon Cancer, Asthma and More

BioSpace

Sun, 04/21/19 - 10:35 pm

Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More

Xconomy

Sun, 04/21/19 - 12:16 am

Adverum Biotechnologies

Blackstone Life Sciences

CRISPR edits out a deadly lung disease in mice before birth

Fierce Biotech

Wed, 04/17/19 - 10:52 pm

First U.S. Patients Treated With CRISPR As Gene-Editing Human Trials Get Underway

NPR

Tue, 04/16/19 - 11:14 am

Living the CRISPR dream

Pharmaforum

Thu, 03/28/19 - 09:56 am

Caribou Biosciences

CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M

Xconomy

Thu, 03/21/19 - 09:35 am

Sherlock Biosciences

Call For CRISPR Moratorium Echoes Early Days Of Gene Therapy

Forbes

Sat, 03/16/19 - 12:29 pm

UC strengthens CRISPR IP position with new patent

BioCentury

Tue, 03/12/19 - 06:49 pm

University of California

Lundbeck fund backs a $50M launch round for SNIPR Biome, a new brand of CRISPR Cas biotech

Endpoints

Mon, 03/11/19 - 09:56 am

Lundbeck Foundation

Could CRISPR Diagnostics Provide a Valuable Weapon in the Fight against Pandemic Flu?

Medical Devices and Diagnostics Industry

Sun, 03/10/19 - 12:02 pm

Pages